Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M; Groupe de Cancérologie Cutanée, Groupe Français de Pneumo-Cancérologie, and Club Rhumatismes et Inflammations. Tison A, et al. Among authors: misery l. Arthritis Rheumatol. 2019 Dec;71(12):2100-2111. doi: 10.1002/art.41068. Epub 2019 Oct 21. Arthritis Rheumatol. 2019. PMID: 31379105
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.
Chabbert C, Adamski H, Guillet G, Sassolas B, Misery L, Perrinaud A, Machet L, Quereux G, Esteve E, Solau-Gervais E, Saraux A, Polard E, Lesimple T, Le Gall F, Dreno B, Dupuy A. Chabbert C, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1540-4. doi: 10.1111/jdv.12347. Epub 2013 Dec 13. J Eur Acad Dermatol Venereol. 2014. PMID: 24329560
Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion.
Sevrain M, Richard MA, Barnetche T, Rouzaud M, Villani AP, Paul C, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L. Sevrain M, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:13-6. doi: 10.1111/jdv.12561. J Eur Acad Dermatol Venereol. 2014. PMID: 24985558 Review.
Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review.
Rouzaud M, Sevrain M, Villani AP, Barnetche T, Paul C, Richard MA, Jullien D, Misery L, Le Maître M, Aractingi S, Aubin F, Joly P, Cantagrel A, Ortonne JP, Beylot-Barry M. Rouzaud M, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:17-26. doi: 10.1111/jdv.12562. J Eur Acad Dermatol Venereol. 2014. PMID: 24985559 Review.
Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines.
Sevrain M, Villani AP, Rouzaud M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L. Sevrain M, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:33-9. doi: 10.1111/jdv.12564. J Eur Acad Dermatol Venereol. 2014. PMID: 24985561 Review.
Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.
Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M, Aractingi S, Aubin F, Cantagrel A, Ortonne JP, Jullien D. Villani AP, et al. Among authors: misery l. J Am Acad Dermatol. 2015 Aug;73(2):242-8. doi: 10.1016/j.jaad.2015.05.001. Epub 2015 Jun 6. J Am Acad Dermatol. 2015. PMID: 26054432 Review.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases. Joly P, et al. Among authors: misery l. Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22. Lancet. 2017. PMID: 28342637 Clinical Trial.
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.
Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O. Sbidian E, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16. J Eur Acad Dermatol Venereol. 2017. PMID: 28609574 Free article.
637 results